Daf Yomi

Chullin 56 · Startup voice, On-ramp

June 25, 2026

Hook

Every founder faces the "inspection dilemma." You have a product, a process, or a partnership that shows signs of distress—a "weasel bite" in the corporate skull. Do you poke it with a needle, looking for any possible reason to kill the deal, burn the asset, and write off the loss? Or do you approach it with a "hand"—gentle, perhaps less precise, but aimed at preservation?

The market is filled with "needle-inspectors": consultants and risk-averse middle managers who would rather sacrifice a perfectly viable asset than take responsibility for a potential flaw. They "waste the money of the Jewish people" (or your shareholders) by deeming everything tereifa (forbidden) because they lack the nuance to distinguish between a superficial scratch and a terminal wound. Conversely, you have the reckless, who ignore the membrane entirely, feeding "carcasses" to the public, risking your brand’s integrity for the sake of short-term velocity.